S1PR1 and Alzheimer disease: These findings are in good agreement with the previously reported ability of the selective S1P1 agonist SEW2871 to reduce Aβ‐induced caspase‐3 activation, hippocampal neuronal death and cognitive impairment in AD rats [57].